G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway

Neurobiology of Aging

Volumn 28, Issue 8, 2007, Pages 1258-1269

  Huang, Hsin Yi ^a,b   Lin, Shinn Zong ^a   Kuo, Jon Son ^b   Chen, Wu Fu ^c   Wang, Mei Jen ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

6 Hydroxydopamine; Bad; Bcl xL; Caspase 3; Dopaminergic neurons; ERK; Granulocyte colony stimulating factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOPAMINE; PROTEIN BAD; PROTEIN BCL XL; STAT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ENZYME ACTIVATION; MALE; MESENCEPHALON; NERVE CELL INHIBITION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SUBSTANTIA NIGRA;

ADRENERGIC AGENTS; ANIMALS; CELL DEATH; CELLS, CULTURED; DOPAMINE; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GRANULOCYTE COLONY-STIMULATING FACTOR; MESENCEPHALON; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR;

EID: 34249329851     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.05.037     Document Type: Article

References (47)

1. Abe K., and Saito H. Neurotrophic effect of basic fibroblast growth factor is mediated by the p42/p44 mitogen-activated protein kinase cascade in cultured rat cortical neurons. Brain Res Dev Brain Res 122 (2000) 81-85
2. Andersen J.K. Does neuronal loss in Parkinson's disease involve programmed cell death?. Bioassays 23 (2001) 640-646
3. Basu S., Dunn A., and Ward A. G-CSF: function and modes of action. Int J Mol Med 10 (2002) 3-10
4. Boneberg E.M., and Hartung T. Molecular aspects of anti-inflammatory action of G-CSF. Inflam Res 51 (2002) 119-128
5. Boneberg E.M., and Hartung T. Granulocyte colony-stimulating factor attenuates LPS-stimulated IL-1β release via suppressed processing of proIL-1β, whereas TNF-α release is inhibited on the level of proTNF-α formation. Eur J Immunol 32 (2002) 1717-1725
6. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., and Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286 (1999) 1358-1362
7. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 109 (2002) 1139-1142
8. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 57 (1999) 86-94
9. Cohen G., and Heikkila R. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxy-dopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249 (1974) 2447-2452
10. Collier T.J., and Sortwell C.E. Therapeutic potential of nerve growth factors in Parkinson's disease. Drugs Aging 14 (1999) 261-287
11. Corti S., Locatelli F., Strazzer S., Salani S., Del Bo R., Soligo D., et al. Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Exp Neurol 177 (2002) 443-452
12. Demetri G.D., and Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 78 (1991) 2791-2808
13. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5 (1996) 449-460
14. Gao H.M., Hong J.S., Zhang W., and Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22 (2002) 782-790
15. Gibson C.L., Bath P.M., and Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25 (2005) 431-439
16. Hagg T., and Varon S. Ciliary neurotrophic factor prevents degeneration of adult sunstantia nigra dopaminergic neurons in vivo. Proc Natl Acad Sci USA 90 (1993) 6315-6319
17. Han B.H., and Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 20 (2000) 5775-5781
18. Han B.S., Hong H.S., Choi W.S., Markelonis G.J., Oh T.H., and Oh Y.J. Caspase-dependent and independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci 23 (2003) 5069-5078
19. Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 5 (1998) 221-225
20. Henze C., Lescot T., Traver S., Salthun-Lassalle B., Hirsch E.C., Michel P.P., et al. Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro. Neurosci Lett 383 (2005) 44-48
21. Hyman C., Hofer M., Barde Y-A, Juhasz M., Yancopoulos G.D., Squinto S.P., et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350 (1991) 230-232
22. Javitch J.A., D'Amato R.J., Strittmatter S.M., and Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82 (1985) 2173-2177
23. Jenner P., and Olanow W. Understanding cell death in Parkinson's disease. Ann Neurol 44 Suppl. 1 (1998) S72-S84
24. Jin K., Mao X.O., Zhu Y., and Greenberg D.A. MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J Neurochem 80 (2002) 119-125
25. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., et al. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26 (2006) 402-413
26. Konishi Y., Chui D.H., Hirose H., Kunishita T., and Tabira T. Trophic effects of erythropoietin and other hematopoieti factors on central cholinergic neurons in vitro and in vivo. Brain Res 609 (1993) 29-35
27. Liang Q.H., Liou A.K.F., Ding Y.M., Cao G.D., Xiao X., Perez R.G., et al. 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. J Neurosci Res 77 (2004) 747-761
28. Lindsay R.M., Altar C.A., Cedarbaum J.M., Hyman C., and Wiegand S.J. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp Neurol 124 (1993) 103-118
29. Lotharius J., Dugan L.L., and O'Malley K.L. Distinct mechanisms underlie neutroxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19 (1999) 1284-1293
30. Meuer K., Pitzer C., Teismann P., Kruger C., Goricke B., Laage R., et al. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem 97 (2006) 675-686
31. Moller J.C., Sautter J., and Kupsch A. Potential of neurotrophic factors in therapy of Parkinson's disease. J Neural Transm Suppl 48 (1996) 103-112
32. Natsume A., Mata M., Goss J., Huang S., Wolfe D., Oligino T., et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol 169 (2001) 231-238
33. Nicholson S.E., Novak U., Ziegler S.F., and Layton J.E. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 86 (1995) 3698-3704
34. Nielsen M., Kaestel C.G., Eriksen K.W., Woetmann A., Stokkedal T., Kaltoft K., et al. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13 (1999) 735-738
35. Obata K., Yamanaka H., Dai Y., Tachibana T., Fukuoka T., Tokunaga A., et al. Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci 15 (2003) 4117-4126
36. Rios-Munoz W., Soto I., Duprey-Diaz M.V., Blagburn J., and Blanco R.E. Fibroblast growth factor 2 applied to the optic nerve after axotomy increases Bcl-2 and decreases Bax in ganglion cells by activating the extracellular signal-regulated kinase signaling pathway. J Neurochem 93 (2005) 1422-1433
37. Sacha C., and Jonsson G. Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24 (1975) 1-8
38. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34 (2003) 745-751
39. Scheid M.P., Schubert K.M., and Duronio V. Regulation of Bad phosphorylation and association with Bcl-xL by the MAPK/Erk kinase. J Biol Chem 274 (1999) 31108-31113
40. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115 (2005) 2083-2098
41. Schulz J.B., Bremen D., Reed J.C., Lommatzsch J., Takayama S., Wullner U., et al. Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species. J Neurochem 69 (1997) 2075-2086
42. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., and Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59 (1992) 99-106
43. Stridh H., Kimland M., Jones D.P., Orrenius S., and Hampton M.B. Cytochrome c release and caspase activation in hydrogen peroxide and tributyltin-induced apoptosis. FEBS Lett 429 (1998) 351-355
44. Wu X., Zhu D., Jiang X., Okagaki P., Mearow K., Zhu G., et al. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression. J Neurochem 90 (2004) 807-818
45. Xia Z.G., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of Erk and Jan-p38 Map kinases on apoptosis. Science 270 (1995) 1326-1331
46. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., and Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80 (1995) 285-291
47. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-628